Assignee
CRISPR THERAPEUTICS AG
CH83 patents
Top patents by PatentIndex Score
US11008586B2May 18, 2021
Universal donor cells
CRISPR THERAPEUTICS AG10 citations94
US11008587B2May 18, 2021
Universal donor cells
CRISPR THERAPEUTICS AG9 citations94
US10865424B2Dec 15, 2020
Universal donor cells
CRISPR THERAPEUTICS AG18 citations94
US10736919B2Aug 11, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG13 citations94
US10724052B2Jul 28, 2020
Universal donor cells
CRISPR THERAPEUTICS AG21 citations94
US11071755B1Jul 27, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US10881689B2Jan 5, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US10857184B2Dec 8, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG9 citations92
US10729725B2Aug 4, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US11434505B2Sep 6, 2022
Universal donor cells
CRISPR THERAPEUTICS AG6 citations86
US11433103B2Sep 6, 2022
Universal donor cells
CRISPR THERAPEUTICS AG6 citations86
US11166985B2Nov 9, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG10 citations86
US11118195B2Sep 14, 2021
Universal donor cells
CRISPR THERAPEUTICS AG9 citations86
US11118196B2Sep 14, 2021
Universal donor cells
CRISPR THERAPEUTICS AG9 citations86
US11116797B2Sep 14, 2021
Universal donor cells
CRISPR THERAPEUTICS AG9 citations86
US11104918B2Aug 31, 2021
Universal donor cells
CRISPR THERAPEUTICS AG9 citations86
US11578309B2Feb 14, 2023
Universal donor cells
CRISPR THERAPEUTICS AG7 citations84
US11566230B2Jan 31, 2023
Universal donor cells
CRISPR THERAPEUTICS AG9 citations84
US11298378B2Apr 12, 2022
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG2 citations84
US11207351B2Dec 28, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG3 citations84
US11202802B2Dec 21, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG2 citations84
US11191783B2Dec 7, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG6 citations84
US11180776B1Nov 23, 2021
Universal donor cells
CRISPR THERAPEUTICS AG6 citations84
US11135247B2Oct 5, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG6 citations84
US11013767B2May 25, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG5 citations84
US11559588B2Jan 24, 2023
Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders
CRISPR THERAPEUTICS AG12 citations83
US11254912B2Feb 22, 2022
Methods and compositions for treating cancer
CRISPR THERAPEUTICS AG5 citations80
US12427170B2Sep 30, 2025
Universal donor cells
CRISPR THERAPEUTICS AG2 citations75
US12378572B2Aug 5, 2025
Universal donor cells
CRISPR THERAPEUTICS AG2 citations75
US12365915B2Jul 22, 2025
Universal donor cells
CRISPR THERAPEUTICS AG2 citations75
US11622977B2Apr 11, 2023
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG1 citations73
US11471491B1Oct 18, 2022
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG1 citations73
US11459372B2Oct 4, 2022
Gene-edited natural killer cells
CRISPR THERAPEUTICS AG3 citations72
US10662425B2May 26, 2020
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
CRISPR THERAPEUTICS AG3 citations71
US11072792B2Jul 27, 2021
Materials and methods for treatment of usher syndrome type 2A
CRISPR THERAPEUTICS AG2 citations70
US11649438B2May 16, 2023
Methods and compositions for treating cancer
CRISPR THERAPEUTICS AG2 citations69
US11591381B2Feb 28, 2023
Gene-edited natural killer cells
CRISPR THERAPEUTICS AG2 citations69
US12122998B2Oct 22, 2024
Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
CRISPR THERAPEUTICS AG2 citations68
US11679130B2Jun 20, 2023
Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG1 citations68
US11497773B2Nov 15, 2022
Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG2 citations68
US11118177B2Sep 14, 2021
Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
CRISPR THERAPEUTICS AG3 citations68
US11866727B2Jan 9, 2024
Materials and methods for treatment of glycogen storage disease type 1A
CRISPR THERAPEUTICS AG4 citations67
US11332760B2May 17, 2022
Compositions and methods for genomic editing by insertion of donor polynucleotides
CRISPR THERAPEUTICS AG2 citations64
US11529427B2Dec 20, 2022
Gene editing for hemophilia A with improved factor VIII expression
CRISPR THERAPEUTICS AG2 citations63
US12584144B2Mar 24, 2026
Universal donor cells
CRISPR THERAPEUTICS AG0 citations62
US12577582B2Mar 17, 2026
Universal donor cells
CRISPR THERAPEUTICS AG0 citations62
US12344656B2Jul 1, 2025
Genetically engineered T cells having improved persistence in culture
CRISPR THERAPEUTICS AG0 citations62
US12304968B2May 20, 2025
T-cells expressing anti-LIV1 chimeric antigen receptor
CRISPR THERAPEUTICS AG0 citations62
US12146157B2Nov 19, 2024
Anti-PTK7 immune cell cancer therapy
CRISPR THERAPEUTICS AG0 citations62
US11926676B2Mar 12, 2024
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such
CRISPR THERAPEUTICS AG1 citations62
Showing the top 50 of 83 patents by PatentIndex Score.